These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26615014)

  • 1. [The use of metabolomics in medicine - some examples of oncological and metabolic diseases].
    Zimny D; Szatkowska M; Połubok J; Maciaszek J; Machaj M; Barg E
    Pediatr Endocrinol Diabetes Metab; 2015; 20(2):55-62. PubMed ID: 26615014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Metabolomics in Childhood Leukemia Diagnostics.
    Kozioł A; Pupek M
    Arch Immunol Ther Exp (Warsz); 2022 Nov; 70(1):28. PubMed ID: 36342560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers.
    Lubes G; Goodarzi M
    J Pharm Biomed Anal; 2018 Jan; 147():313-322. PubMed ID: 28750734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic investigation of human diseases biomarkers by CE and LC coupled to MS.
    Buzatto AZ; de Sousa AC; Guedes SF; Cieslarová Z; Simionato AV
    Electrophoresis; 2014 May; 35(9):1285-307. PubMed ID: 24375663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach.
    Caboni P; Meloni A; Lussu M; Carta E; Barberini L; Noto A; Deiana SF; Mereu R; Ragusa A; Paoletti AM; Melis GB; Fanos V; Atzori L
    J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():4-12. PubMed ID: 25284171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
    Trezzi JP; Vlassis N; Hiller K
    Adv Exp Med Biol; 2015; 867():41-57. PubMed ID: 26530359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics-A Promising Approach to Pituitary Adenomas.
    Pînzariu O; Georgescu B; Georgescu CE
    Front Endocrinol (Lausanne); 2018; 9():814. PubMed ID: 30705668
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
    Antonucci R; Atzori L; Barberini L; Fanos V
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics: a new tool for the neonatologist.
    Atzori L; Antonucci R; Barberini L; Griffin JL; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():50-3. PubMed ID: 19701858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies.
    Wang X; Sun H; Zhang A; Wang P; Han Y
    J Sep Sci; 2011 Dec; 34(24):3451-9. PubMed ID: 21826791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
    Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
    Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic studies of breast cancer in murine models: A review.
    Araújo R; Bispo D; Helguero LA; Gil AM
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165713. PubMed ID: 32014550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.
    Kumar D; Gupta A; Nath K
    Expert Rev Mol Diagn; 2016 Jun; 16(6):651-61. PubMed ID: 26959614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial metabolomics: A pilot mass spectrometry and NMR study of the human plasma metabolome in response to a challenge meal.
    Karimpour M; Surowiec I; Wu J; Gouveia-Figueira S; Pinto R; Trygg J; Zivkovic AM; Nording ML
    Anal Chim Acta; 2016 Feb; 908():121-31. PubMed ID: 26826694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.